Literature DB >> 1609294

Treatment of locally advanced breast cancer.

D J Booser1, G N Hortobagyi.   

Abstract

It is possible to convert most patients with stage III breast cancer to the state of "no evidence of disease." The challenges now are to increase the cure rate by eradicating local and distant micrometastatic disease, and to minimize the mutilation of locoregional treatment.

Entities:  

Mesh：

Year:  1992        PMID： 1609294

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


  15 in total

Review 1.  Neoadjuvant chemoimmunotherapy in locally advanced breast cancer: a new avenue to be explored.

Authors:  Jan Buter; Herbert M Pinedo
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

Review 2.  FDG-PET in monitoring therapy of breast cancer.

Authors:  H-J Biersack; H Bender; H Palmedo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-27       Impact factor: 9.236

3.  Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy.

Authors:  H J Shin; H H Kim; J H Ahn; S-B Kim; K H Jung; G Gong; B H Son; S H Ahn
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

4.  (99m)Tc-sestamibi scintigraphy used to evaluate tumor response to neoadjuvant chemotherapy in locally advanced breast cancer: A quantitative analysis.

Authors:  Katia Hiromoto Koga; Sonia Marta Moriguchi; Jorge Nahás Neto; Stela Verzinhasse Peres; Eduardo Tinóis DA Silva; Almir José Sarri; Odair Carlito Michelin; Mariangela Esther Alencar Marques; Beatriz Lotufo Griva
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

5.  Multidisciplinary approach to the treatment of unresectable breast cancer.

Authors:  Z Z Shen; Y W Zhang; T X Pan; C J Xia
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

6.  Intra-arterial administration of adriamycin-loaded albumin microspheres for locally advanced breast cancer.

Authors:  J C Doughty; J H Anderson; N Willmott; C S McArdle
Journal:  Postgrad Med J       Date:  1995-01       Impact factor: 2.401

Review 7.  In vivo 1H MRS in the assessment of the therapeutic response of breast cancer patients.

Authors:  Uma Sharma; Hyeon Man Baek; Min Ying Su; Naranamangalam R Jagannathan
Journal:  NMR Biomed       Date:  2011-01-28       Impact factor: 4.044

Review 8.  Locally advanced breast cancer in developing countries: the place of surgery.

Authors:  Justus P Apffelstaedt
Journal:  World J Surg       Date:  2003-06-06       Impact factor: 3.352

9.  Durable remission of locally advanced breast cancer with multimodality management.

Authors:  A Miller; P Khosla; J Lynch; J Moreb; S Cullins; H Safah; C Hutchison; V La Russa; K Vellis; J Rice; N Mendenhall; R Weiner
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

10.  Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer.

Authors:  M M Kim; P Allen; A M Gonzalez-Angulo; W A Woodward; F Meric-Bernstam; A U Buzdar; K K Hunt; H M Kuerer; J K Litton; G N Hortobagyi; T A Buchholz; E A Mittendorf
Journal:  Ann Oncol       Date:  2013-04-05       Impact factor: 32.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.